top of page

Publications

The use of multiple respiratory inhalers requiring different inhalation techniques has an adverse effect on COPD outcomes

2 November 2017

International Journal of Chronic Obstructive Pulmonary Disease

Sinthia Bosnic-Anticevich, Henry Chrystyn, Richard W Costello, Myrna B Dolovich, Monica J Fletcher, Federico Lavorini, Roberto Rodríguez-Roisin, Dermot Ryan, Simon Wan Yau Ming, David Price

Fractional exhaled nitric oxide as a predictor of response to inhaled corticosteroids in patients with non-specific respiratory symptoms and insignificant bronchodilator reversibility: a randomised controlled trial

2 November 2017

The Lancet Respiratory Medicine

David Price, Roland Buhl, Adrian Chan, Daryl Freeman, Elizabeth Gardener, Clifford Godley, Kevin Gruffydd-Jones, Lorcan McGarvey, Ken Ohta, Dermot Ryan, Jörgen Syk, Ngiap Chuan Tan, TzeLee Tan, Mike Thomas, Sen Yang, Priyanka Raju Konduru, Marcus Ngantcha, Martina Stagno d’Alcontres, Therese S Lapperre

Lack of asthma and rhinitis control in general practitioner-managed patients prescribed fixed dose combination therapy in Australia

4 September 2017

Journal of Asthma

Bosnic-Anticevich S, Kritikos V, Carter V, Yan KY, Armour C, Ryan D, David Price

Medication-related costs of rhinitis in Australia: a NostraData cross-sectional study of pharmacy purchases

4 September 2017

Journal of Asthma and Allergy

Smith P, David Price, Harvey R, Carney AS, Kritikos V, Bosnic-Anticevich SZ, Christian L, Skinner D, Carter V, Durieux AMS

Seasonal patterns of oral antihistamine and intranasal corticosteroid purchases from Australian community pharmacies: a retrospective observational study

29 August 2017

Pragmatic and Observational Research

A Simon Carney, David Price, Pete K Smith, Richard Harvey, Vicky Kritikos, Sinthia Z Bosnic-Anticevich, Louise Christian, Derek A Skinner, Victoria Carter, Alice MS Durieux

The comparative effectiveness of initiating fluticasone/salmeterol combination therapy via pMDI versus DPI in reducing exacerbations and treatment escalation in COPD: a UK database study

16 August 2017

International Journal of Chronic Obstructive Pulmonary Disease

Rupert Jones, Jessica Martin, Vicky Thomas, Derek Skinner, Jonathan Marshall, Martina Stagno d’Alcontres, David Price

Inhaler errors in the CRITIKAL study: type, frequency, and association with asthma outcomes

31 July 2017

Journal of Allergy and Clinical Immunology: In Practice

David Price, Miguel Román-Rodríguez, R. Brett McQueen, Sinthia Bosnic-Anticevich, Victoria Carter, Kevin Gruffydd-Jones, John Haughney, Svein Henrichsen, Catherine Hutton, Antonio Infantino, Federico Lavorini, Lisa M. Law, Karin Lisspers, Alberto Papi, Dermot Ryan, Björn Ställberg, Thys van der Molen, Henry Chrystyn

Full Text

Blood eosinophil count and exacerbation risk in patients with COPD

19 July 2017

European Respiratory Journal

Marjan Kerkhof, Samatha Sonnappa, Dirkje S. Postma, Guy Brusselle, Alvar Agustí, Antonio Anzueto, Rupert Jones, Alberto Papi, Ian Pavord, Emilio Pizzichini, Todor Popov, Nicolas Roche, Dermot Ryan, Mike Thomas, Claus Vogelmeier, Alison Chisholm, Daryl Freeman, Mona Bafadhel, Elizabeth V. Hillyer, David Price

Impact of spacers on therapeutic ratio with inhaled corticosteroids

30 June 2017

Journal of Allergy and Clinical Immunology: In Practice

Theresa W. Guilbert, David Price

Pub Med

Initiating or changing to a fixed-dose combination of fluticasone propionate/formoterol over fluticasone propionate/salmeterol: a real-life effectiveness and cost impact evaluation

23 June 2017

Respiratory Medicine

Simon Wan Yau Ming, John Haughney, Iain Small, Stephanie Wolfe, John Hamill, Kevin Gruffydd-Jones, Cathal Daly, Joan B. Soriano, Elizabeth Gardener, Derek Skinner, Martina Stagno d’Alcontres, David Price

Risk of pneumonia in obstructive lung disease: a real-life study comparing extra-fine and fine-particle inhaled corticosteroids

14 June 2017

PLOS ONE

Samatha Sonnappa, Richard J. Martin, Elliot Israel, Dirkje Postma, Wim van Aalderen, Anne Burden, David Price, Omar S. Usmani

Real-life effectiveness and safety of the inhalation suspension budesonide comparator vs the originator product for the treatment of patients with asthma: a historical cohort study using a US health claims database

17 May 2017

Pragmatic and Observational Research

David Price, Eran Gefen, Gokul Gopalan, Cristiana Miglio, Rosie McDonald, Vicky Thomas, Simon Wan Yau Ming

Ipratropium/Salbutamol comparator versus originator for chronic obstructive pulmonary disease exacerbations: US observational cohort study using the Clinformatics™ health claims database

23 April 2017

Pulmonary Therapy

Vicky Thomas, Eran Gefen, Gokul Gopalan, Rafael Mares, Rosie McDonald, Simon Wan Yau Ming, David Price

Pub Med

Does co-payment for inhaler devices affect therapy adherence and disease outcomes? A historical, matched cohort study

17 April 2017

Pragmatic and Observational Research

Jaco Voorham, Bernard Vrijens, Job FM van Boven, Dermot Ryan, Marc Miravitlles, Lisa M Law, David Price

Cardiovascular risks in smokers treated with nicotine replacement therapy: a historical cohort study

16 April 2017

Clinical Epidemiology

Jens Dollerup, Jørgen Vestbo, Tarita Murray-Thomas, Alan Kaplan, Richard J Martin, Emilio Pizzichini, Marcia M M Pizzichini, Anne Burden, Jessica Martin, David Price

Cohort analysis of exacerbation rates in adolescent and adult patients initiating inhaled corticosteroids for asthma: different dose-response profile by particle size

11 April 2017

Pulmonary Therapy

Dirkje S. Postma, Alan Kaplan, Joan B. Soriano, Jonathon Grigg, Theresa W. Guilbert, Wim van Aalderen, Nicolas Roche, Anne Burden, Elizabeth V. Hillyer, Elliot Israel, David Price

Pub Med

A randomized pragmatic trial of changing to and stepping down fluticasone/formoterol in asthma

24 March 2017

Journal of Allergy and Clinical Immunology: In Practice

Omar S. Usmani, Anu Kemppinen, Elizabeth Gardener, Vicky Thomas, Priyanka Raju Konduru, Christina Callan, Andrew McLoughlin, Vanessa Woodhead, Adam Brady, Elizabeth F Juniper, Peter J Barnes, David Price

Comparative effectiveness of step-up therapies in children with asthma prescribed inhaled corticosteroids: a historical cohort study

24 March 2017

Journal of Allergy and Clinical Immunology: In Practice

Clare S. Murray, Mike Thomas, Kathryn Richardson, David Price, Steve W. Turner

An evaluation of exact matching and propensity score methods as applied in a comparative effectiveness study of inhaled corticosteroids in asthma

21 March 2017

Pragmatic and Observational Research

Anne Burden, Nicolas Roche, Cristiana Miglio, Elizabeth V. Hillyer, Dirkje S. Postma, R. Brett McQueen, Ron M.C. Herings, Jetty A. Overbeek, Javaria Mona Khalid, Daniela van Eickels, Joan B. Soriano, David Price

Real-life outcomes for patients with asthma prescribed spacers for use with either extrafine- or fine-particle inhaled corticosteroids

17 January 2017

Journal of Allergy and Clinical Immunology: In Practice

Theresa W. Guilbert, Gene Colice, Jonathan Grigg, Wim van Aalderen, Richard J. Martin, Elliot Israel, Dirkje S. Postma, Nicolas Roche, Wanda Phipatanakul, Elizabeth V. Hillyer, Jennifer M. Evans, Myrna B. Dolovich, David Price, Respiratory Effectiveness Group

Opri Logo White
An academic research institution striving to improve the lives of patients.
Company
Observational and Pragmatic Research Institute (registered in Singapore) 
Observational Pragmatic Research International (registered in England and Wales)
thumbnail_IMS-white-ISO_9001_ISO_27001-removebg-preview.png

Certificate
No: 385342022

GBC Accreditation
2025 Ecovadis.png
Designer_edited.png
Follow Us
  • Instagram
  • Threads
  • LinkedIn
  • X
Contact Us
Email:
info@opri.sg 
Tel:
(+65) 3105 1489 
Address
OPRI Singapore
22 SIN MING LANE #06-76, MIDVIEW CITY,(573969) 
OPRI UK
Warren House, Sankence, Aylsham, Norwich NR11 6UN
OPRI 2025 All Rights Reserved
bottom of page